Skip to content
10-Q

Quarterly Report

Lexeo Therapeutics, Inc. LXEO

0001193125-25-265757

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 72.99M sh
Shares Diluted Q3 2025 · Sep 30, 2025 60.98M sh
Shares Diluted Q3 2025 · Sep 30, 2025 45.99M sh
Shares Diluted Q3 2025 · Sep 30, 2024 33.06M sh
Shares Diluted Q3 2025 · Sep 30, 2024 31.35M sh
Capex Q3 2025 · Sep 30, 2025 $397K
Capex Q3 2025 · Sep 30, 2024 $481K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$78.48M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$52.83M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $41M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $35.01M
Stockholders Equity Q3 2025 · Sep 30, 2025 $120.83M
Stockholders Equity Q3 2025 · Jun 30, 2025 $138.22M
Stockholders Equity Q3 2025 · Mar 31, 2025 $88.12M
Stockholders Equity Q3 2025 · Dec 31, 2024 $116.84M
Stockholders Equity Q3 2025 · Sep 30, 2024 $139.33M
Stockholders Equity Q3 2025 · Jun 30, 2024 $164.95M
Stockholders Equity Q3 2025 · Mar 31, 2024 $182.95M
Stockholders Equity Q3 2025 · Dec 31, 2023 $113.54M
Current Liabilities Q3 2025 · Sep 30, 2025 $17.27M
Current Liabilities Q3 2025 · Dec 31, 2024 $22.85M
Total Liabilities Q3 2025 · Sep 30, 2025 $23.01M
Total Liabilities Q3 2025 · Dec 31, 2024 $30.1M
Current Assets Q3 2025 · Sep 30, 2025 $127.79M
Current Assets Q3 2025 · Dec 31, 2024 $126.12M
Total Assets Q3 2025 · Sep 30, 2025 $143.84M
Total Assets Q3 2025 · Dec 31, 2024 $146.94M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.33
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.72
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.89
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.31
Eps Basic Q3 2025 · Sep 30, 2025 −$0.33
Eps Basic Q3 2025 · Sep 30, 2025 −$1.72
Eps Basic Q3 2025 · Sep 30, 2024 −$0.89
Eps Basic Q3 2025 · Sep 30, 2024 −$2.31
Sga Expense Q3 2025 · Sep 30, 2025 $5.95M
Sga Expense Q3 2025 · Sep 30, 2025 $38.55M
Sga Expense Q3 2025 · Sep 30, 2024 $8.12M
Sga Expense Q3 2025 · Sep 30, 2024 $22.66M
Rd Expense Q3 2025 · Sep 30, 2025 $15.7M
Rd Expense Q3 2025 · Sep 30, 2025 $47.59M
Rd Expense Q3 2025 · Sep 30, 2024 $23.42M
Rd Expense Q3 2025 · Sep 30, 2024 $55.73M
Net Income Q3 2025 · Sep 30, 2025 −$20.28M
Net Income Q3 2025 · Sep 30, 2025 −$79.04M
Net Income Q3 2025 · Jun 30, 2025 −$26.1M
Net Income Q3 2025 · Mar 31, 2025 −$32.66M
Net Income Q3 2025 · Dec 31, 2024 −$98.3M
Net Income Q3 2025 · Sep 30, 2024 −$29.49M
Net Income Q3 2025 · Sep 30, 2024 −$72.41M
Net Income Q3 2025 · Jun 30, 2024 −$21.24M
Net Income Q3 2025 · Mar 31, 2024 −$21.68M
Operating Income Q3 2025 · Sep 30, 2025 −$21.65M
Operating Income Q3 2025 · Sep 30, 2025 −$86.14M
Operating Income Q3 2025 · Sep 30, 2024 −$31.54M
Operating Income Q3 2025 · Sep 30, 2024 −$78.38M